Trials / Terminated
TerminatedNCT03727087
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 348 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.
Detailed description
Subjects will have been recently diagnosed with untreated melanoma. Subjects will have a blood sample collected at enrollment and provide medical history prior to initiation of treatment. There will be no further follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Sample Collection | Subjects participating in the study will have blood drawn at enrollment. |
Timeline
- Start date
- 2019-01-10
- Primary completion
- 2020-03-24
- Completion
- 2020-03-24
- First posted
- 2018-11-01
- Last updated
- 2021-02-10
Locations
36 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03727087. Inclusion in this directory is not an endorsement.